عـرض براءة الإختـراع

Development of novel tetra nuclear distorted square anti-prism Dy (III) imine complex for pharmaceutical and industrial applications

• رقــم البراءة

  US 11,873,313 B1

• المجـال العلمى

  الصحة - Health

• سنة الإصدار

  2024

• مكتـب التسجيـل

  مكتب البراءات الأمريكي - US Patent Office

• أسماء المخترعين

  Ahmed; Hany Mohamed Ab El-Lateef (Al-Ahsa, SA), Ali; Mai Mustafa Khalaf (Al-Ahsa, SA), Abu-Dief; Ahmed M. (Al-Madina Al-Mounawara, SA), Abdelbaky; Mohammed S. M. (Oviedo, ES), Garcia-Granda; Santiago (Oviedo, ES)

• نبذة عن البـراءة

  Provided are tetra nuclear distorted square anti-prism Dy (III) imine complexes, and their use in pharmaceutical and industrial applications. These complexes can be formed as a Schiff base-metal complex. The Schiff base-metal complex can comprise a Dy.sub.4L.sub.4ES.sub.2(H.sub.2O) H.sub.2O complex, wherein L is 2-Ethoxy-6-[(2-hydroxy-phenylimino)-methyl]-phenol; and ES is deprotonated 3-ethoxysalicylaldehyde.